Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication.

Naik RP, Streiff MB, Haywood C Jr, Nelson JA, Lanzkron S.

Am J Med. 2013 May;126(5):443-9. doi: 10.1016/j.amjmed.2012.12.016.

2.

Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.

Yu TT, Nelson J, Streiff MB, Lanzkron S, Naik RP.

Thromb Res. 2016 May;141:35-8. doi: 10.1016/j.thromres.2016.03.003. Epub 2016 Mar 2.

3.

Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.

Naik RP, Streiff MB, Haywood C Jr, Segal JB, Lanzkron S.

J Thromb Haemost. 2014 Dec;12(12):2010-6. doi: 10.1111/jth.12744. Epub 2014 Oct 18.

4.

Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.

Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A.

Pediatrics. 2008 Apr;121(4):777-82. doi: 10.1542/peds.2007-0730.

PMID:
18381543
5.

Venous thromboembolism in adults with sickle cell disease: experience of a single centre in the UK.

van Hamel Parsons V, Gardner K, Patel R, Thein SL.

Ann Hematol. 2016 Jan;95(2):227-32.

PMID:
26490882
6.

Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.

Brunson A, Lei A, Rosenberg AS, White RH, Keegan T, Wun T.

Br J Haematol. 2017 Jul;178(2):319-326. doi: 10.1111/bjh.14655. Epub 2017 Apr 3.

PMID:
28369826
7.

Sickle cell disease and venous thromboembolism in pregnancy and the puerperium.

Noubouossie D, Key NS.

Thromb Res. 2015 Feb;135 Suppl 1:S46-8. doi: 10.1016/S0049-3848(15)50442-8. Epub 2015 Feb 9. Review.

PMID:
25903535
8.

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP.

N Engl J Med. 2004 Feb 26;350(9):886-95.

9.

Impact of sickle hemoglobinopathies on pregnancy-related venous thromboembolism.

Porter B, Key NS, Jauk VC, Adam S, Biggio J, Tita A.

Am J Perinatol. 2014 Oct;31(9):805-9. doi: 10.1055/s-0033-1361931. Epub 2013 Dec 12.

PMID:
24338132
10.

The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom.

Cabrita IZ, Mohammed A, Layton M, Ghorashian S, Gilmore A, Cho G, Howard J, Anie KA, Desforges L, Bassett P, Grapsa J, Howard L, Mahalingam G, Dawson D, Pinto FJ, Nihoyannopoulos P, Davies SC, Gibbs JS.

Br J Haematol. 2013 Aug;162(3):400-8. doi: 10.1111/bjh.12391. Epub 2013 May 29.

PMID:
23713628
11.

Elevated tricuspid regurgitant jet velocity, reduced forced expiratory volume in 1 second, and mortality in adults with sickle cell disease.

Chaturvedi S, Labib Ghafuri D, Kassim A, Rodeghier M, DeBaun MR.

Am J Hematol. 2017 Feb;92(2):125-130. doi: 10.1002/ajh.24598.

PMID:
27806442
12.

Echocardiography-derived tricuspid regurgitant jet velocity is an important marker for the progression of sickle-cell disease.

Upadhya B, Stacey RB, Ntim W, Knovich MA, Pu M.

Acta Haematol. 2014;132(2):152-8.

PMID:
24577318
13.

Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.

Naik RP, Streiff MB, Lanzkron S.

J Thromb Thrombolysis. 2013 Apr;35(3):352-8. doi: 10.1007/s11239-013-0895-y. Review.

14.

Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis.

Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP.

J Bone Joint Surg Am. 2010 Sep 15;92(12):2156-64. doi: 10.2106/JBJS.I.00882.

PMID:
20844157
15.

Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysis.

Seaman CD, Yabes J, Li J, Moore CG, Ragni MV.

Thromb Res. 2014 Dec;134(6):1249-52. doi: 10.1016/j.thromres.2014.09.037. Epub 2014 Oct 5.

PMID:
25306185
16.

Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.

Faller N, Limacher A, Méan M, Righini M, Aschwanden M, Beer JH, Frauchiger B, Osterwalder J, Kucher N, Lämmle B, Cornuz J, Angelillo-Scherrer A, Matter CM, Husmann M, Banyai M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky D.

Am J Med. 2017 Feb;130(2):198-206. doi: 10.1016/j.amjmed.2016.09.008. Epub 2016 Oct 11.

PMID:
27742261
17.

Risk factors for venous thromboembolism in children.

Gerotziafas GT.

Int Angiol. 2004 Sep;23(3):195-205. Review.

PMID:
15765033
18.
19.

Venous thromboembolism in heart failure: preventable deaths during and after hospitalization.

Piazza G, Goldhaber SZ, Lessard DM, Goldberg RJ, Emery C, Spencer FA.

Am J Med. 2011 Mar;124(3):252-9. doi: 10.1016/j.amjmed.2010.10.014.

PMID:
21396509
20.

A cross-sectional evaluation of venous thromboembolism risk and use of venous thromboembolism prophylaxis in hospitalized patients in Senegal.

Bâ SA, Badiane SB, Diop SN, Diouf FS, Fall D, Ka MM, Kane A, Ndiaye M; Comité TROMBUS Senegal.

Arch Cardiovasc Dis. 2011 Oct;104(10):493-501. doi: 10.1016/j.acvd.2011.05.007. Epub 2011 Sep 1.

Supplemental Content

Support Center